Clinical Trials Directory

Trials / Unknown

UnknownNCT04131608

Effect of Iron Deficiency Anemia on HBA1C in Patients With Diabetic Foot Ulcer Grade (1and2)

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Diabetic foot ulcer is the commonest cause of severe limb ischemia in diabetes mellitus And development of anemia is an additional burden to the microvascular complications of diabetes

Detailed description

HBA1C is the predominant Hemoglobin found in HBA1 fraction and it constitutes 5% of total Hemoglobin in normal adults and up to 15%in patients with diabetes mellitus HBA1C is used to diagnose diabetes and to identify individuals that are at high risk for developing diabetes Iron deficiency anemia is one of the most prevalent form of malnutrition affect 1,62 billion people whish correspond to 24,8%of the world population Ferritin is the storage form of iron so it is found to be test for distinguishing those with iron deficiency anemia from those who are not iron deficient

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCBC ,Serum ferritin ,HBA1CDiabetic patients will be applied to CBC, HBA1C and serum ferritin

Timeline

Start date
2021-02-01
Primary completion
2021-10-01
Completion
2021-12-01
First posted
2019-10-18
Last updated
2021-01-13

Source: ClinicalTrials.gov record NCT04131608. Inclusion in this directory is not an endorsement.